Serina Therapeutics Inc (SER)

Serina Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	82	15	21	41	57	69
Market Cap Growth	33.77%	-30.23%	-49.36%	-27.81%	-16.39%	-36.04%
Enterprise Value	84	11	22	54	63	68
PE Ratio	7.80	2.77	-7.81	-4.77	-5.27	-5.64
PS Ratio	25.95	4.63	35.41	287.18	158.69	39.65
PB Ratio	-7.81	-0.45	-0.55	-3.49	-11.20	30.89
P/FCF Ratio	-12.43	-4.90	-10.04	-5.26	-7.31	-6.34
P/OCF Ratio	-15.38	-5.90	-10.09	-5.26	-7.33	-6.74
EV/Sales Ratio	26.69	3.39	37.57	374.46	174.67	39.42
EV/EBITDA Ratio	-34.81	1.75	-9.05	-7.24	-6.85	-6.15
EV/EBIT Ratio	-26.99	1.83	-8.34	-7.12	-6.03	-5.66
EV/FCF Ratio	-13.29	-3.59	-10.66	-6.86	-8.05	-6.31
Debt / Equity Ratio	-2.57	-0.11	-0.05	-1.12	-1.23	0.88
Debt / EBITDA Ratio	-10.72	0.61	-0.74	-1.77	-0.68	-0.18
Debt / FCF Ratio	-4.09	-1.24	-0.87	-1.68	-0.80	-0.18
Quick Ratio	0.63	5.39	1.22	0.07	0.16	0.82
Current Ratio	0.64	5.39	1.25	0.25	0.43	1.23
Asset Turnover	0.28	0.27	0.29	0.05	0.08	0.18
Interest Coverage	-	10.44	-167.92	-6.91	-25.89	-
Return on Equity (ROE)	4.10%	-20.70%	13.80%	96.20%	363.70%	-214.90%
Return on Assets (ROA)	-8.00%	45.80%	-131.50%	-307.60%	-241.80%	-127.30%
Return on Capital (ROIC)	-48.62%	10.94%	6.31%	-546.35%	-847.03%	-300.89%
Earnings Yield	-1.09%	36.07%	-12.81%	-20.98%	-18.97%	-17.74%
FCF Yield	-3.31%	-20.40%	-9.96%	-18.99%	-13.68%	-15.76%
Buyback Yield / Dilution	67.44%	-86.72%	-99.12%	-0.58%	-1.07%	-6.75%
Total Shareholder Return	67.44%	-86.72%	-99.12%	-0.58%	-1.07%	-6.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).